Valuation: Qinghai Spring Medicinal Resources Technology Co., Ltd.

Market Cap 2.4B 358M 318M 297M 271M 510M 34.48B 517M 3.6B 1.39B 17.56B 1.34B 1.32B 56.4B P/E 2024
-10.7x
P/E 2025 -63.3x
Enterprise Value 2.24B 334M 296M 277M 253M 475M 32.12B 482M 3.35B 1.3B 16.36B 1.25B 1.23B 52.55B EV / Sales 2024
7x
EV / Sales 2025 6.91x
Free-Float
52.61%
Yield 2024 *
-
Yield 2025 -
08-29 Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
04-29 Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-16 Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
25-10-20 Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-27 Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-04-29 Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-28 Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
24-10-30 Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
24-10-01 Qinghai Spring Medicinal Resources Technology Unit Fined 1.3 Million Yuan for 'Misleading Commercial Propaganda' MT
24-08-01 Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 CI
24-07-17 Tranche Update on Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback Plan announced on April 19, 2024. CI
24-07-16 Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback announced on April 19, 2024, has closed with 14,703,805 shares, representing 2.5% for CNY 33.74 million. CI
24-07-01 Tranche Update on Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback Plan announced on April 19, 2024. CI
1 day+1.69%
1 month-3.67%
3 months-19.54%
6 months+36.81%
Current year-5.19%
1 week 4.06
Extreme 4.06
4.26
1 month 3.74
Extreme 3.74
4.45
Current year 2.48
Extreme 2.48
5.9
1 year 2.48
Extreme 2.48
5.9
3 years 1.84
Extreme 1.84
8.43
5 years 1.84
Extreme 1.84
20.67
10 years 1.84
Extreme 1.84
20.67
Manager TitleAgeSince
Chief Executive Officer 57 2015-10-29
Director of Finance/CFO 57 2018-05-17
Corporate Secretary 59 2014-04-13
Director TitleAgeSince
Chairman 57 2015-10-29
Director/Board Member 56 2015-05-14
Chairman 57 2020-06-03
Change 5-day change 1-year change 3-year change Capi.($)
+1.69%-.--%-14.46%-47.30% 358M
-0.62%-2.71%+39.30%+114.07% 1,031B
-2.30%-4.44%+39.03%+66.07% 638B
-0.63%-1.96%+6.36%+74.38% 462B
-1.03%-2.82%+59.56%+39.69% 359B
-0.03%-3.96%+23.63%+39.35% 335B
-1.58%-0.76%+13.50%+25.77% 273B
-2.02%-2.97%-3.25%+8.38% 253B
-3.38%+0.30%+36.44%+51.54% 228B
-1.04%-1.46%+32.70%+96.82% 185B
Average -1.10%-1.74%+23.28%+46.88% 376.42B
Weighted average by Cap. -1.25%-1.89%+30.51%+69.17%

Financials

2024 2025
Net sales 270M 40.26M 35.76M 33.44M 30.47M 57.37M 3.88B 58.16M 405M 157M 1.97B 151M 148M 6.34B 343M 51.16M 45.44M 42.49M 38.72M 72.9M 4.93B 73.91M 514M 199M 2.51B 192M 188M 8.06B
Net income -199M -29.61M -26.3M -24.59M -22.41M -42.19M -2.85B -42.77M -298M -115M -1.45B -111M -109M -4.66B -37.32M -5.56M -4.94M -4.62M -4.21M -7.92M -535M -8.03M -55.87M -21.63M -273M -20.87M -20.42M -876M
Net Debt -196M -29.22M -25.95M -24.27M -22.12M -41.64M -2.81B -42.21M -294M -114M -1.43B -110M -107M -4.6B -164M -24.45M -21.72M -20.31M -18.51M -34.85M -2.35B -35.32M -246M -95.12M -1.2B -91.81M -89.82M -3.85B
Logo Qinghai Spring Medicinal Resources Technology Co., Ltd.
QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO.,LTD is a China-based company that principally engaged in the integrated development, utilization, production, sales and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company’s main products are the cordyceps sinensis series products under Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis and raw cordyceps sinensis. The Company’s subsidiary is Qinghai Spring Pharmaceutical Resource Utilization Co Ltd.
Employees
134
Date Price Change Volume
26-09-30 CN¥4.200 +1.69% 4,133,500
26-09-29 CN¥4.130 -.--% 4,678,500
26-09-28 CN¥4.130 -1.67% 3,476,900
26-09-24 CN¥4.200 -3.23% 5,160,900
26-09-23 CN¥4.340 +1.88% 8,430,101
  1. Stock Market
  2. Stocks
  3. 600381 Stock